Rapid Increase of Community SARS-CoV-2 Seroprevalence during Second Wave of COVID-19, Yaoundé, Cameroon.
COVID-19
Cameroon
SARS-CoV-2
antibodies
coronavirus disease
respiratory infections
seroepidemiologic studies
severe acute respiratory syndrome coronavirus 2
viruses
zoonoses
Journal
Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155
Informations de publication
Date de publication:
06 2022
06 2022
Historique:
pubmed:
27
4
2022
medline:
25
5
2022
entrez:
26
4
2022
Statut:
ppublish
Résumé
We conducted 2 independent population-based SARS-CoV-2 serosurveys in Yaoundé, Cameroon, during January 27-February 6 and April 24-May 19, 2021. Overall age-standardized SARS-CoV-2 IgG seroprevalence increased from 18.6% in the first survey to 51.3% in the second (p<0.001). This finding illustrates high community transmission during the second wave of COVID-19.
Identifiants
pubmed: 35470795
doi: 10.3201/eid2806.212580
pmc: PMC9155890
doi:
Substances chimiques
Antibodies, Viral
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1233-1236Références
EClinicalMedicine. 2021 Nov;41:101172
pubmed: 34723165
Clin Infect Dis. 2022 Mar 9;74(5):882-890
pubmed: 34089598
Clin Infect Dis. 2021 Aug 2;73(3):e699-e709
pubmed: 33400782
J Clin Virol. 2020 Aug;129:104521
pubmed: 32623350
BMC Med. 2021 Nov 19;19(1):303
pubmed: 34794434
Rev Med Virol. 2022 Mar;32(2):e2271
pubmed: 34228851
Emerg Infect Dis. 2021 Dec;27(12):3020-3029
pubmed: 34477548
Lancet Glob Health. 2021 May;9(5):e588-e589
pubmed: 33609481
Clin Infect Dis. 2022 Mar 23;74(6):1030-1038
pubmed: 34185847